An Indian Post Marketing Study of Mealtime Insulin, Fiasp®, to Evaluate Its Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice
Clinical trial NCT03987802 · COMPLETED
Trial details
- NCT number
- NCT03987802
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-20
- Primary completion
- 2022-06-28
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.